- PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab. OncoImmunology. 2018 In Process GET IT
- Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors. Journal of Molecular Diagnostics. 2018 Academic Article GET IT
Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing.
Times cited: 8
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
Times cited: 1